{
    "id": 23223,
    "fullName": "KRAS G60D",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KRAS G60D lies within the switch II region of the Kras protein (PMID: 20617134). G60D has been identified in the scientific literature (PMID: 25303977, PMID: 21632860), but has not been biochemically characterized and therefore, its effect on Kras protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 1805,
                    "pubMedId": 20617134,
                    "title": "Clinical relevance of KRAS in human cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20617134"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 7006,
                    "pubMedId": 25303977,
                    "title": "Mutational landscape of aggressive cutaneous squamous cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25303977"
                },
                {
                    "id": 10056,
                    "pubMedId": 21632860,
                    "title": "Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21632860"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3845,
        "geneSymbol": "KRAS",
        "terms": [
            "KRAS",
            "'C-K-RAS",
            "C-K-RAS",
            "c-Ki-ras",
            "c-Ki-ras2",
            "CFC2",
            "K-Ras",
            "K-Ras 2",
            "K-RAS2A",
            "K-RAS2B",
            "K-RAS4A",
            "K-RAS4B",
            "KI-RAS",
            "KRAS1",
            "KRAS2",
            "NS",
            "NS3",
            "OES",
            "RALD",
            "RASK2"
        ]
    },
    "variant": "G60D",
    "createDate": "06/14/2016",
    "updateDate": "10/20/2019",
    "referenceTranscriptCoordinates": {
        "id": 157195,
        "transcript": "NM_033360",
        "gDna": "chr12:g.25227345C>T",
        "cDna": "c.179G>A",
        "protein": "p.G60D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20356,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a non-small cell lung cancer patient harboring CCDN1 amplification, KRAS G60D, and MET D1010N via plasma testing demonstrated stable disease for 3.8 months when treated with Glesatinib (MGCD265), but then progressed, and plasma testing revealed acquisition of ERBB3 (HER3) amplification (PMID: 32034073).",
            "molecularProfile": {
                "id": 35153,
                "profileName": "CCND1 amp ERBB3 amp KRAS G60D MET D1010N"
            },
            "therapy": {
                "id": 809,
                "therapyName": "Glesatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17807,
                    "pubMedId": 32034073,
                    "title": "Molecular mechanisms of acquired resistance to MET tyrosine kinase inhibitors in patients with MET exon 14 mutant NSCLC.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/32034073"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23903,
            "profileName": "KRAS G60D",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35153,
            "profileName": "CCND1 amp ERBB3 amp KRAS G60D MET D1010N",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 157194,
            "transcript": "NM_004985",
            "gDna": "chr12:g.25227345C>T",
            "cDna": "c.179G>A",
            "protein": "p.G60D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157198,
            "transcript": "XM_006719069",
            "gDna": "chr12:g.25227345C>T",
            "cDna": "c.179G>A",
            "protein": "p.G60D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157195,
            "transcript": "NM_033360",
            "gDna": "chr12:g.25227345C>T",
            "cDna": "c.179G>A",
            "protein": "p.G60D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157196,
            "transcript": "XM_017019293",
            "gDna": "chr12:g.25227345C>T",
            "cDna": "c.179G>A",
            "protein": "p.G60D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157197,
            "transcript": "XM_011520653",
            "gDna": "chr12:g.25227345C>T",
            "cDna": "c.179G>A",
            "protein": "p.G60D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}